Company Filing History:
Years Active: 2012
Title: Anton Gerdenitsch: Innovator in Pharmaceutical Production
Introduction
Anton Gerdenitsch is a notable inventor based in Rohrbach, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the production of high-purity compounds. His innovative methods have the potential to enhance the quality and efficacy of pharmaceutical raw materials.
Latest Patents
Gerdenitsch holds a patent for a method of producing high-purity 4a, 5, 9, 10, 11, 12-hexahydro-6H-benzofuro [3a, 3, 2-ef] [2] benzazepine and its derivatives. This process involves the production of extremely pure galanthamine and its derivatives. The method includes debromination of racemic bromine narwedine under palladium catalysis, followed by a reaction mixture worked up in the presence of oxygen or peroxides. This results in the palladium catalyst being converted into an insoluble form for easy separation. Further reactions lead to the reduction of enantiomerically pure narwedine to form enantiomerically pure galanthamine, which can then be alkylated or dealkylated. The process ensures that residual palladium levels are below 5 ppm, allowing the pure galanthamine to be used directly as a pharmaceutical raw material. He has 1 patent to his name.
Career Highlights
Gerdenitsch is associated with Sanochemia Pharmazeutika AG, where he applies his expertise in pharmaceutical production. His work has been instrumental in advancing methods that ensure the purity and effectiveness of pharmaceutical compounds.
Collaborations
He has collaborated with notable colleagues such as Stefan Welzig and Jan Rothenburger, contributing to the innovative environment at Sanochemia Pharmazeutika AG.
Conclusion
Anton Gerdenitsch is a key figure in the pharmaceutical industry, with a focus on producing high-purity compounds that can significantly impact medical treatments. His innovative methods and collaborations highlight his commitment to advancing pharmaceutical science.